The Effect of Repeated Whole-body NMES Sessions With or Without Protein Intake on Muscle Protein Synthesis During 3 Days of Bed Rest in Healthy Young Volunteers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorWageningen University

About this trial

The goal of this clinical trial is to examine the effect of whole-body electrostimulation with protein intake on muscle protein synthesis, muscle mass and function during bed rest in healthy young adults (18-35 years). The main questions to answer are:

* Does whole-body NMES followed by protein intake improve muscle protein synthesis rates during 3 days of bed rest? * Does repeated NMES sessions offer protective effects on muscle mass and function during extended periods of inactivity?

Researchers will compare sham electrical electrostimulation, electrical stimulation and electrical stimulation + protein groups to see if whole-body electrostimulation combined with protein intake offers the greatest improvement in muscle protein metabolism and muscle preservation.

Participants will:

* Undergo 3 days of bed rest while receiving one of the following interventions:

* Sham-NMES followed by standard nutrition (CON) * Whole-body NMES followed by standard nutrition(NMES) * Whole-body NMES followed by a bolus of 20g protein (NMES+PRO) * Receive heavy water (D2O) to assess body water turnover. * Undergo leg extension exercises to assess muscle function. * Have quadriceps muscle thickness measured via ultrasound. * Provide saliva samples for analysis. * Have calf circumference measured to monitor changes in muscle mass.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged from 18-35 years

18.5 < BMI < 30 kg·m2

Recreationally active (performing non-competitive physical exercise at least one time per week for minimally 30 minutes)

Disqualifiers

Employed or undertaking a thesis or internship at the department of Human and Animal Physiology at Wageningen University

Smoking

Diabetes (Type 1, Type 2, or genetic form of diabetes)

Any diagnosed cardiovascular (heart) disease or high blood pressure (≥140 mmHg systolic and/or

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sham (No Treatment)

    Other intervention

    A placebo treatment in which no actual electrical stimulation is delivered, serving as a control for the active NMES.

  • NMES

    Other intervention

    Active neuromuscular electrical stimulation applied to the entire body to induce muscle contractions through small electric currents.

  • Protein bolus (20g)

    Dietary supplement

    A bolus dose of 20 grams of protein provided after the NMES intervention to assess the combined effect of muscle stimulation and protein intake on muscle protein metabolism.

  • Standard nutrition

    Other intervention

    Provision of a normal Western standardized diet.

Treatment groups

42 Participants
are divided into 3 treatment groups
Group A: Control groupSham comparator 2 interventions
Group B: Whole-body NMES groupActive comparator 2 interventions
Group C: Whole-body NMES + protein groupActive comparator 3 interventions

Trial outcomes

Primary outcomes

1

Cumulative myofibrillar fractional synthesis rate

A measure of muscle protein synthesis between two given time points.

Time frame
Habitual MPS (Day -2 to Day 0), Acute effect of NMES (+protein bolus) (0 hours to 5 hours on Day 0), Bedrest MPS (Day 0 to Day 3),

Secondary outcomes

1

Quadriceps Muscle Layer Thickness

Assessed using ultrasound, this measures changes in muscle size, indicating muscle loss or preservation during bed rest and NMES intervention.

Time frame
Between Day -21 and Day -5, Day 0, Day 3, Day 6, Week 6
2

Body Composition

Evaluates muscle mass to determine overall changes.

Time frame
Day 0 and Day 3.
3

Body composition

Evaluates fat distribution to determine overall changes.

Time frame
Time Frame: Day 0 and Day 3.
4

Quadriceps Muscle Function

Assessed via a leg dynamometer.

Time frame
Between Day -21 and Day -5, Day 0, Day 3, Day 6, Week 6

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.